tiprankstipranks
Advertisement
Advertisement

NBP Stock Latest News

NovaBridge Biosciences Sets September 8, 2026 AGM in Shanghai and Highlights 2025 Annual Filing
Company AnnouncementsNovaBridge Biosciences Sets September 8, 2026 AGM in Shanghai and Highlights 2025 Annual Filing
10d ago
6K
NBP
NovaBridge Biosciences Launches 2026 Omnibus Share Incentive Plan
PremiumCompany Announcements
NovaBridge Biosciences Launches 2026 Omnibus Share Incentive Plan
17d ago
6K
NBP
NovaBridge Biosciences Names New CEO Amid Broad Board and Executive Shake-Up
PremiumCompany Announcements
NovaBridge Biosciences Names New CEO Amid Broad Board and Executive Shake-Up
1M ago
6K
NBP
NovaBridge CEO Xi-Yong Fu to step down, Srishti Gupta to succeed
PremiumThe Fly
NovaBridge CEO Xi-Yong Fu to step down, Srishti Gupta to succeed
1M ago
NBP
NovaBridge Biosciences Replaces PwC With Deloitte as Independent Auditor
PremiumCompany Announcements
NovaBridge Biosciences Replaces PwC With Deloitte as Independent Auditor
2M ago
6K
NBP
NovaBridge Wins FDA Fast Track for Givastomig in First-Line Gastric Cancer
PremiumCompany AnnouncementsNovaBridge Wins FDA Fast Track for Givastomig in First-Line Gastric Cancer
2M ago
6K
NBP
NovaBridge Biosciences Names Veteran Deal-Maker Mark Hagler President and CCO to Steer Late-Stage Oncology and Eye-Drug Push
Premium
Company Announcements
NovaBridge Biosciences Names Veteran Deal-Maker Mark Hagler President and CCO to Steer Late-Stage Oncology and Eye-Drug Push
3M ago
6K
NBP
NovaBridge Biosciences Highlights 2025 Results and Advances Late-Stage Oncology and Ophthalmology Programs
Premium
Company Announcements
NovaBridge Biosciences Highlights 2025 Results and Advances Late-Stage Oncology and Ophthalmology Programs
4M ago
6K
NBP
IMAB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
IMAB Upcoming Earnings Report: What to Expect?
4M ago
NBP
NovaBridge Wins FDA Backing for Accelerated Approval Pathway for Givastomig in Gastric Cancer
PremiumCompany Announcements
NovaBridge Wins FDA Backing for Accelerated Approval Pathway for Givastomig in Gastric Cancer
5M ago
6K
NBP
NovaBridge had ‘productive’ FDA meeting on potential gastric cancer treatment
PremiumThe Fly
NovaBridge had ‘productive’ FDA meeting on potential gastric cancer treatment
5M ago
NBP
NovaBridge and Visara Post Strong VIS-101 Phase 2a Wet AMD Data, Plot Path to Late-Stage Trials
PremiumCompany Announcements
NovaBridge and Visara Post Strong VIS-101 Phase 2a Wet AMD Data, Plot Path to Late-Stage Trials
5M ago
6K
NBP
NovaBridge, Visara announce results from VIS-101 Phase 2a Wet AMD study
PremiumThe FlyNovaBridge, Visara announce results from VIS-101 Phase 2a Wet AMD study
5M ago
NBP
NovaBridge Biosciences Sets March 9 Call to Review Phase 2a VIS-101 Data in Wet AMD
Premium
Company Announcements
NovaBridge Biosciences Sets March 9 Call to Review Phase 2a VIS-101 Data in Wet AMD
5M ago
6K
NBP
NovaBridge Biosciences Unveils February Investor Deck Detailing Global Hub-and-Spoke Biotech Strategy
Premium
Company Announcements
NovaBridge Biosciences Unveils February Investor Deck Detailing Global Hub-and-Spoke Biotech Strategy
5M ago
6K
NBP
NovaBridge appoints Cunningham as Vice Chairman of Board of Directors
PremiumThe Fly
NovaBridge appoints Cunningham as Vice Chairman of Board of Directors
6M ago
NBP
NovaBridge Biosciences Names Emmett Cunningham Vice Chairman to Bolster Biotech Platform
PremiumCompany Announcements
NovaBridge Biosciences Names Emmett Cunningham Vice Chairman to Bolster Biotech Platform
6M ago
6K
NBP
NovaBridge enrolls first patient in givastomig combination study
PremiumThe Fly
NovaBridge enrolls first patient in givastomig combination study
6M ago
NBP
NovaBridge Doses First Patient in Global Phase 2 Gastric Cancer Trial of Givastomig
PremiumCompany Announcements
NovaBridge Doses First Patient in Global Phase 2 Gastric Cancer Trial of Givastomig
6M ago
6K
NBP
Amazon downgraded, Roblox upgraded: Wall Street’s top analyst calls
PremiumThe FlyAmazon downgraded, Roblox upgraded: Wall Street’s top analyst calls
6M ago
EL
PI
NovaBridge Biosciences Unveils February 2026 Investor Presentation Highlighting Global Hub-and-Spoke Biotech Strategy
Premium
Company Announcements
NovaBridge Biosciences Unveils February 2026 Investor Presentation Highlighting Global Hub-and-Spoke Biotech Strategy
6M ago
6K
NBP
Reaffirming Buy on NovaBridge Biosciences: Differentiated Givastomig Profile, Expanded Patient Reach, and Strengthened Long-Term Value Proposition
Premium
Ratings
Reaffirming Buy on NovaBridge Biosciences: Differentiated Givastomig Profile, Expanded Patient Reach, and Strengthened Long-Term Value Proposition
6M ago
NBP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >